Quality Assurance by electromagnetic Tracking in Interstitial multi-catheter HDR Brachytherapy Using a hybrid Afterloading System (2018) Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Retrospective inconsistent analysis cannot validate safety of a treatment strategy (2018) Strnad V Journal article Immune suppressive properties of Glioblastoma cells might result in part from radiation-induced increased expression of inhibitory immune checkpoint molecules (2018) Langenfelder E, Derer A, Fietkau R, Gaipl U, Frey B Conference contribution Influence of radiotherapy-induced reactive oxygen species on the immunogenic potential of HPV plus in comparison to HPV-HNSCC (2018) Peitz L, Frey B, Rieckmann T, Fietkau R, Gaipl U Conference contribution Fractionated LINAC-SBRT for Adrenal Gland Metatases: Dose-Dependence of Therapy Results (2018) Knippen S, Burjakow K, Putz F, Achterberg N, Lettmaier S, Fietkau R Conference contribution Impact of hypo- and normofractionated radiation on cell death and senescence of HNSCC-cells of different HPV-Status (2018) Wild K, Peitz L, Rieckmann T, Fietkau R, Frey B, Gaipl U Conference contribution Immune modulation by low dose radiation therapy-results from 70 patients followed up in the IMMO-LDRT01 study (2018) Donaubauer AJ, Gryc T, Becker I, Harrer A, Rühle PF, Ott OJ, Fietkau R, et al. Conference contribution GLIO-CMV-01: Identification of immune biomarkers for CMV-related encephalitis during radiotherapy of the brain (2018) Donaubauer AJ, Becker I, Rühle PF, Goerig N, Pohn A, Winkler T, Korn K, et al. Conference contribution Enhancing the Effect of Combination Therapy with the PARP Inhibitor Talazoparib and ionizing Radiation on Melanoma Cell Lines (2018) Proebstle S, Jost T, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Investigation of a radioprotective Effect of the Kinase Inhibitor Palbociclib on Melanoma Cells in a 3D Cell Culture Model (2018) Jost T, Buerkel F, Proebstle S, Hecht M, Fietkau R, Distel L Conference contribution